available for iOS, Android and web
January 14, 2013
The European Medicines Agency has issued a statement saying that "there is no reason for any woman" to stop using combined contraception amid safety fears
December 09, 2011
Advisors to the US Food and Drug Administration say the benefits of Bayer's Yaz contraceptive franchise outweigh the risks but have recommended label changes
April 28, 2011
The safety of Bayer's oral contraceptive Yasmin has been called into question on the back of new research suggesting the pill's drospirenone component may present a higher risk of blood clots than levonorgestrel-based rivals.
January 07, 2011
Bayer has filed to expand the indications for its oral anticoagulant Xarelto in Europe beyond its current use in preventing venous thromboembolism in patients undergoing hip or knee replacement surgery.
October 19, 2010
Bayer Schering Pharma’s Xarelto for the treatment of venous thromboembolism has won the 2010 UK Prix Galien Innovative Product Award, fighting off stiff competition from five other products.
September 23, 2010
Taking antipsychotics could increase by nearly a third the risk of developing dangerous blood clots, an observational study published in the BMJ has found.
PharmaTimes 2014 Copyright | RSS Feed Subscriptions